gdc
PSSGuide_2021
Gastric Cancer

Drugs for GIST (Gastrointestinal Stromal Tumor)

Here are the drugs and financial support services available to patients receiving treatment for GIST (Gastrointestinal Stromal Tumor).

Ayvakit (avapritinib) Tablets

Drug company: Blueprint Medicines
888-258-7768

Ayvakit is a tyrosine kinase inhibitor used for the treatment of patients with unresectable or metastatic gastrointestinal stromal tumor (GIST) harboring a PDGFRA exon 18 mutation, including PDGFRA D842V mutation.

Blueprint Medicines offers 5 financial assistance programs for patients who have been prescribed Ayvakit:

YourBlueprint Co-Pay Assistance Program

Eligible patients who have private or commercial insurance will pay as little as $0 per a prescription of Ayvakit.

YourBlueprint Patient Assistance Program

Patients who are uninsured, or who have limited insurance, may be eligible to receive Ayvakit for free. Patients must reside in the United States and meet the financial eligibility criteria.

QuickStart Program

Eligible patients may be able to receive a 15-day supply of medication at no cost through this program while waiting to get their insurance coverage.

Coverage Interruption Program

Patients who change their insurance or have a temporary interruption in their insurance coverage may be eligible to get a temporary no-cost supply of the medication.

Ayvakit Dose Exchange Program

Patients who had their dose of Ayvakit adjusted by their doctor can trade their remaining medication for the new dose at no cost.

Gleevec (imatinib mesylate) Tablets

Drug company: Novartis
800-245-5356

Gleevec is a kinase inhibitor used for the treatment of patients with Kit (CD117)-positive unresectable, recurrent and/or metastatic GIST, and as an adjuvant treatment.

Novartis’ Patient Assistance NOW Oncology offers 3 financial assistance programs for patients using Gleevec:

Gleevec Patient Support Program

This program offers patient counselors, educational information, and financial assistance resources, such as the Gleevec $10 Co-Pay Card.

Novartis Oncology Universal Co-pay Program

Patients with private insurance may pay only $10 for a 30-day supply of Gleevec, with a maximum of $10,630 for a 30-day supply and up to an annual maximum of $30,000.

Novartis Patient Assistance Foundation

Patients who are experiencing financial hardship and have limited or no public or private prescription coverage may be able to receive Gleevec for free through the Novartis Patient Assistance Foundation. To be eligible for financial assistance, the patient must be a US citizen and must provide proof of income that meets the financial eligibility requirements. Eligible patients may receive Gleevec for free until prescription drug coverage becomes available to them.

Qinlock (ripretinib) Tablets

Drug company: Deciphera
833-432-2237

Qinlock is a kinase inhibitor used for the treatment of adults with advanced GIST who have received 3 or more previous kinase inhibitors, including imatinib.

Deciphera offers 2 financial assistance programs for patients who have been prescribed Qinlock:

Commercial Copay Program

This program will cover all out-of-pocket drug costs so that eligible patients who have commercial or private insurance pay as little as $0 copay.

Patient Assistance Program

Eligible patients who do not have insurance, or whose coverage does not cover the cost of Qinlock, may qualify to receive Qinlock for free through this program.

Stivarga (regorafenib) Tablets

Drug company: Bayer
866-639-2827

Stivarga is a kinase inhibitor used for the treatment of patients with locally advanced, unresectable, or metastatic GIST after treatment with imatinib or sunitinib malate.

Bayer offers 2 financial assistance programs for patients using Stivarga:

STIVARGA $0 Co-Pay Program

Through this program, patients with private insurance will have a $0 copay for Stivarga, up to $25,000 per patient annually.

REACH Patient Assistance Program

Uninsured or underinsured patients who are prescribed Stivarga should contact the Resources for Expert Assistance and Care Helpline (REACH) services counselor to possibly qualify for free medication.

Sutent (sunitinib malate) Capsules

Drug company: Pfizer
877-744-5675

Sutent is a kinase inhibitor used for the treatment of patients with GIST.

Pfizer Oncology Together offers 2 financial assistance programs for patients using Sutent:

Pfizer Oncology Together Co-Pay Savings Program

This Pfizer program assists eligible patients with private insurance so that their copay for Sutent is $0 monthly, with a maximum savings of up to $25,000 annually.

Pfizer Patient Assistance Program

This program serves patients who are either uninsured or those with government insurance. Uninsured patients may qualify to receive Sutent for free or at a savings. Eligible patients with government insurance who cannot find independent charitable foundation support may receive Sutent for free.

Table. Drugs Prescribed for GIST (Gastrointestestinal Stromal Tumor)

  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services


    Drug name (generic name)
  • Qinlock (ripretinib) Tablets
  • Drug company
  • Deciphera
  • Indication
  • Treatment of adults with advanced GIST who have received 3 or more kinase inhibitors, including imatinib
  • Patient support services
  • Commercial Copay Program
    833-432-2237

    Patient Assistance Program
    833-432-2237



Share this:

Last modified: April 7, 2021

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link

Subscribe to CONQUER: the patient voice magazine

Receive timely cancer news & updates, patient stories, and more.

Country